STACKWELL is an adaptive protocol intelligence platform that delivers evidence-based peptide protocols, longevity stacks, recovery systems, and metabolic optimization plans. It combines AI-powered personalization with curated scientific research to help users optimize performance, recovery, and healthspan.

What are peptide protocols?

Peptide protocols are structured regimens using bioactive peptides—such as BPC-157, TB-500, Ipamorelin, or CJC-1295—to support specific biological goals including muscle recovery, fat loss, longevity, hormonal optimization, and skin aesthetics. STACKWELL provides evidence-graded protocols with compound-level explanations and weekly progress tracking.

How does STACKWELL's protocol intelligence work?

STACKWELL's adaptive protocol engine analyzes user goals, experience level, and daily check-in data to recommend and adjust protocols over time. It maps compounds to biological pathways, weighs evidence levels (high, moderate, emerging), and surfaces personalized education matched to your active stack.

What health goals does STACKWELL support?

STACKWELL supports seven primary optimization goals: fat loss, muscle gain, recovery, longevity, energy, libido, and skin aesthetics. Each goal has curated compound stacks, evidence-backed education, and adaptive daily tracking.

BioStack AI helps you optimize biology with personalized protocols, 5 stack tools, community insights, education articles, and tracked adoptions in one app.

🔥

Moderatehigh evidence

Incretin Metabolic Research

A comparison of GLP-1-based compounds studied for weight and glucose regulation. These compounds are compared side by side, not combined.

View Research Stack

🔥 fat loss Protocol

Why This Stack Works

All three act on incretin hormone receptors: semaglutide on GLP-1, tirzepatide on GLP-1 and GIP, and retatrutide on GLP-1, GIP and glucagon. They are commonly discussed together to compare mechanisms and clinical trial findings.

Evidence & Transparency

Evidence Levelhigh

MechanismAll three act on incretin hormone receptors: semaglutide on GLP-1, tirzepatide on GLP-1 and GIP, and retatrutide on GLP-1, GIP and glucagon.…

Primary Goalfat loss

Confidence80% confidence

Last Updated1 weeks ago

Research Sources4 sources

Protocol Components

🧬

Retatrutide

metabolic

🧪 Emerging Research

🧬

Tirzepatide

metabolic

📊 Strong Evidence

🧬

Semaglutide

metabolic

📊 Strong Evidence

✓ Best For

Weight management, glucose regulation and appetite signaling research.

⚠ Avoid If

These compounds overlap in mechanism and are not studied in combination. Retatrutide is still investigational. Semaglutide and tirzepatide are prescription medications with known gastrointestinal and other risks.

Related Protocols & Research

Research & Education

Boosting Physical Function in HIV with Tesamorelin and Exercise

A study explores tesamorelin's benefits for physical function in HIV patients through exercise.

Exploring L-Carnitine for Fatigue Relief in Multiple Sclerosis

Can L-carnitine help fight fatigue in MS patients?

Can Retatrutide Help Heart and Kidney Health in People With Obesity?

Exploring retatrutide's effects on heart and kidney health in those with obesity.

Comparing Weight Loss Mechanics: Tirzepatide vs. Semaglutide

Exploring how two popular weight management medications impact energy balance and metabolic health in adults.

Frequently Asked Questions

Protocol information on STACKWELL is for educational purposes only. Not medical advice. Consult a qualified healthcare provider before starting any new health program.